Cancer immune evasion through loss of MHC class I antigen presentation
Hamman, S.R
*Eligible patients without diabetes but with a BMI of 30, or 27 with comorbidities, lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg of tirzepatide, when combined with a reduced-calorie diet and increased physical activity
Compounded GLP-1 microdose medications are only indicated when a prescribing practitioner determines they offer a significant difference from the FDA-approved product, as compounded medications are not reviewed by the FDA for safety, efficacy, or quality
Eat slowly, stay hydrated, and have easy meals prepped or use meal delivery to reduce stress during adjustment
However, other factors can contribute to discomfort, such as: While most cases of post-injection pain resolve within a few hours to days, persistent or worsening symptoms may signal a more serious issue